News - UF Innovate

Glint Pharmaceuticals to Present at OIS/SECO 2023 Ophthalmology Conference

UF startup Glint Pharmaceuticals will present its drug releasing contact lens technology at the OIS SECO 2023 ophthalmology conference, in Atlanta on March 1.

Third Annual Science2Startup Symposium Will Foster Collaboration Between Researchers, Entrepreneurs and Top Investors

Kirill Martemyanov, Ph.D., professor and chair of The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, is one of the 10 presenters selected for the third annual Science2Startup Symposium taking place May 3, 2023.

First ‘Institute Professor’ of The Wertheim UF Scripps Institute Inventing New Ways to Target Incurable Diseases Via RNA

Matthew D. Disney, Ph.D., a professor and chair of the Department of Chemistry at The Wertheim UF Scripps Institute for Biomedical Innovation & Technology, has been named the first “Institute Professor” at the institution.

Glint Pharmaceuticals Receives FDA IND Acceptance for Clinical Study for Phase 1/2 Clinical Trial of Antibiotic Drug-Releasing Contact Lens, ACL5

UF startup Glint Pharmaceuticals (Glint), a clinical-stage biotechnology company focused on developing a next-generation contact lens drug delivery technology, announced that the United States (U.S.) Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application to evaluate its antibiotic drug delivery contact lens, ACL5. Glint anticipates beginning the investigation in Q2 2023.

Florida Tech Corridor Reaches for the Future

They’re among hundreds of innovations powered by the Florida High Tech Corridor, an initiative anchored by a trio of Florida research universities that rings Sumter County. Just marking its 27th anniversary, leaders of Florida’s tech triangle —UF in Gainesville, UCF in Orlando and USF in Tampa — say the future will bring even more revolution.

A Founder’s Collaboration Skills May Be the Key to Success, Especially in Deep Tech

Accelerators like UF Innovate are crucial to the early-stage economy, and to innovation in the United States. It’s at places like these that new technologies can be brought to the market, including technologies that with a profound effect on people’s lives and health. One UF Innovate company, for instance, is MYOLYN, which makes therapy systems for people with neurological disorders and injuries, like multiple sclerosis or stroke.

Using Whole-Genome Sequencing To Study Early-Onset Parkinson’s Disease

The Norwegian term for virgin snow, “nysnø”, seemed the appropriate inspiration to name Jennifer Johnston’s company, NysnoBio, as it underscores the pioneering work NysnoBio is doing to tap the potential of Parkin, the protein most often linked to young onset genetic Parkinson’s disease.

Celebrating a Mentor – College Honors Faculty Members With New Award Named for the Late Mavis Agbandje-McKenna, PhD

Mavis Agbandje-McKenna, PhD, a UF College of Medicine professor in the department of biochemistry and molecular biology and the director of the Center for Structural Biology, dedicated 32 years to advancing discoveries in adeno-associated viruses, or AAV, and other parvoviruses at UF before passing away in 2021. In addition to being a globally recognized parvovirus researcher, she demonstrated an unwavering commitment to training the next generation of scientists.

Nuclear Sleuths: University of Florida To Lead $25 Million National Consortium on Nuclear Forensics

The project, funded by the U.S. Department of Energy’s National Nuclear Security Administration (NNSA), aims to prepare 135 undergraduate, master’s and doctoral students to help federal laboratories throughout the United States address current and future needs in nuclear forensics, and to replace an aging workforce.

City of Jacksonville and University of Florida To Explore Possible New Graduate Campus

The potential project would build on UF’s and Jacksonville’s long-standing connections in health care, providing new graduate education programs aimed at supporting the region’s growing workforce needs in biomedical technology and focused on pioneering technology related to simulation, health applications of artificial intelligence, patient quality and safety, health care administration and fintech.

UF News